Reply to Adler et al

Affiliations

¹ Service d'Hématologie Greffe, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris, France.
² Institut Pasteur, Centre médical, Centre d'Infectiologie Necker-Pasteur, Paris, France.

Comment

Flore Sicre de Fontbrune et al. J Infect Dis. 2018.

. 2018 May 5;217(11):1845-1846.

doi: 10.1093/infdis/jiy051.

¹ Service d'Hématologie Greffe, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris, France.
² Institut Pasteur, Centre médical, Centre d'Infectiologie Necker-Pasteur, Paris, France.

No abstract available

Comment on

Immunogenicity and Safety of Yellow Fever Vaccine in Allogeneic Hematopoietic Stem Cell Transplant Recipients After Withdrawal of Immunosuppressive Therapy.
Sicre de Fontbrune F, Arnaud C, Cheminant M, Boulay A, Konopacki J, Lapusan S, Robin C, Bernaudin F, Suarez F, Simon F, Socié G, Colin de Verdière N, Consigny PH. Sicre de Fontbrune F, et al. J Infect Dis. 2018 Jan 17;217(3):494-497. doi: 10.1093/infdis/jix564. J Infect Dis. 2018. PMID: 29087520
Persistence of Yellow Fever Immunization-Induced Antibodies in Allogeneic Hematopoietic Stem Cell Transplant Recipients.
Adler M, Lapierre V, Sakr R, Bourhis JH, Gachot B, Castilla-Llorente C, Wyplosz B. Adler M, et al. J Infect Dis. 2018 May 5;217(11):1844-1845. doi: 10.1093/infdis/jiy050. J Infect Dis. 2018. PMID: 29547928 No abstract available.